Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS
暂无分享,去创建一个
Shang Gao | Shawn P. Driscoll | Samuel L. Pfaff | Brian K. Kaspar | Zoltan Tomori | Eric T. Ahrens | Atsushi Miyanohara | E. Ahrens | Shang Gao | Z. Tomori | S. Pfaff | Yoshiomi Kobayashi | A. Miyanohara | B. Kaspar | V. Proks | D. Cleveland | M. Marsala | O. Platoshyn | Wenlian Zhu | Don W. Cleveland | J. Juhasova | Yoshiomi Kobayashi | Dara Ditsworth | Oleksandr Platoshyn | Sandrine Da Cruz | Wenlian Zhu | Helena Skalnikova | Mariana Bravo-Hernandez | Takahiro Tadokoro | Michael R. Navarro | Silvia Marsala | Stefan Juhas | Jana Juhasova | Ivo Vanicky | Hana Studenovska | Vladimir Proks | PeiXi Chen | Noe Govea-Perez | Joseph D. Ciacci | Thomas D. Glenn | Melissa McAlonis-Downes | Martin Marsala | S. Da Cruz | H. Studenovska | I. Vanický | Š. Juhás | Helena Skalnikova | D. Ditsworth | J. Ciacci | T. Tadokoro | Melissa McAlonis-Downes | M. Bravo-Hernandez | S. Marsala | PeiXi Chen | Noé Govea-Perez | M. Bravo-Hernández | H. Skalnikova | Hana Studenovska
[1] L. Ferraiuolo,et al. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[2] Robert H. Brown,et al. Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1G93A Mice and Nonhuman Primates , 2015, Human gene therapy.
[3] R. Desimone,et al. A novel flexible cuff-like microelectrode for dual purpose, acute and chronic electrical interfacing with the mouse cervical vagus nerve , 2017, Journal of neural engineering.
[4] D. Borchelt,et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.
[5] J. Rothstein,et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Rivest,et al. Sensorimotor and cognitive functions in a SOD1 G37R transgenic mouse model of amyotrophic lateral sclerosis , 2011, Behavioural Brain Research.
[7] D Linden,et al. Reduced baroreflex sensitivity and cardiorespiratory transfer in amyotrophic lateral sclerosis. , 1998, Electroencephalography and clinical neurophysiology.
[8] J. Julien,et al. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS , 2010, Journal of neurochemistry.
[9] B. Monia,et al. Antisense oligonucleotide therapy for neurodegenerative disease. , 2006, The Journal of clinical investigation.
[10] E. Ahrens,et al. Potent spinal parenchymal AAV9-mediated gene delivery by subpial injection in adult rats and pigs , 2016, Molecular therapy. Methods & clinical development.
[11] Bin Wang,et al. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models , 2018, The Journal of clinical investigation.
[12] M. Scadeng,et al. Analysis of Dosing Regimen and Reproducibility of Intraspinal Grafting of Human Spinal Stem Cells in Immunosuppressed Minipigs , 2010, Cell transplantation.
[13] D. Cleveland,et al. Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond , 2009, The Journal of cell biology.
[14] A. Miyanohara,et al. Improved function of the failing rat heart by regulated expression of insulin-like growth factor I via intramuscular gene transfer. , 2012, Human gene therapy.
[15] R. Samulski,et al. Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus , 1998, Journal of Virology.
[16] B. Fitzsimmons,et al. In Vivo Gene Knockdown in Rat Dorsal Root Ganglia Mediated by Self-Complementary Adeno-Associated Virus Serotype 5 Following Intrathecal Delivery , 2012, PloS one.
[17] Y. Hayashi,et al. Cardiac sympathetic function in the patients with amyotrophic lateral sclerosis: analysis using cardiac [123I] MIBG scintigraphy , 2013, Journal of Neurology.
[18] M. Chapleau,et al. Methods of assessing vagus nerve activity and reflexes , 2011, Heart Failure Reviews.
[19] Y. Itoyama,et al. Disease progression of human SOD1 (G93A) transgenic ALS model rats , 2006, Journal of neuroscience research.
[20] H. Hayashi,et al. Amyotrophic lateral sclerosis with hypertensive attacks: Blood pressure changes in response to drug administration , 1996, Clinical Autonomic Research.
[21] A. Higginbottom,et al. Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS , 2018, Molecular therapy. Nucleic acids.
[22] L. Goldstein,et al. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice , 2008, Proceedings of the National Academy of Sciences.
[23] G. Kollias,et al. Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia , 2006, Science.
[24] E. Feldman,et al. Human Neural Stem Cell Replacement Therapy for Amyotrophic Lateral Sclerosis by Spinal Transplantation , 2012, PloS one.
[25] Y. Li,et al. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis , 2013, Nature Neuroscience.
[26] Robert H. Brown,et al. Adeno‐associated virus–delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model , 2016, Annals of neurology.
[27] Jonathan P. Riley,et al. Preclinical Safety Validation of a Stabilized Viral Vector Direct Injection Approach to the Cervical Spinal Cord , 2009, Clinical and translational science.
[28] D. Cleveland,et al. Enhancing Mitochondrial Calcium Buffering Capacity Reduces Aggregation of Misfolded SOD1 and Motor Neuron Cell Death without Extending Survival in Mouse Models of Inherited Amyotrophic Lateral Sclerosis , 2013, The Journal of Neuroscience.
[29] A. Ferry,et al. A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[30] L. Greensmith,et al. Rodent models of amyotrophic lateral sclerosis. , 2013, Biochimica et biophysica acta.
[31] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[32] Robert H. Brown,et al. Silencing strategies for therapy of SOD1-mediated ALS , 2017, Neuroscience Letters.
[33] Alberto Porta,et al. Cardiovascular neural regulation is impaired in amyotrophic lateral sclerosis patients. A study by spectral and complexity analysis of cardiovascular oscillations , 2015, Physiological measurement.
[34] S. McKeown,et al. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis. , 2016, Gene.
[35] D. Gutmann,et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis , 2008, Nature Neuroscience.
[36] C. Brösamle,et al. `Semifree-floating' treatment: a simple and fast method to process consecutive sections for immunohistochemistry and neuronal tracing , 1997, Journal of Neuroscience Methods.
[37] S. Parikh,et al. Autonomic etiology of heart block in amyotrophic lateral sclerosis: a case report , 2014, Journal of Medical Case Reports.